Download Files:
MG-2119
SKU
HY-139307-10 mg
Category Reference compound
Tags Neurological Disease, Neuronal Signaling, Tau Protein
$500 – $4,200
Products Details
Product Description
– MG-2119 is a potent monomeric tau and α-syn aggregation inhibitor. MG-2119 is a potential agent for neurological disorders research[1].
Web ID
– HY-139307
Storage Temperature
– 4°C (Powder, sealed storage, away from moisture and light)
Shipping
– Room Temperature
Applications
– Neuroscience-Neurodegeneration
Molecular Formula
– C27H29N5O4
References
– [1]Gabr MT, et al. Dual Targeting of Monomeric Tau and α-Synuclein Aggregation: A New Multitarget Therapeutic Strategy for Neurodegeneration. ACS Chem Neurosci. 2020;11(14):2051-2057.
CAS Number
– 1065500-40-4
Molecular Weight
– 487.55
Compound Purity
– 99.60
SMILES
– O=C(C1=CC(NC(COC)=O)=CC2=C1N(CCC3=CC=CC=C3)C=N2)NCC(C)OC4=CC=CN=C4
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Tau Protein
Pathway
– Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.